New data links UPLIZNA treatment to fewer severe attacks and reduced levels of key disease-related biomarkers versus placebo. DUBLIN — Horizon Therapeutics plc (Nasdaq: HZNP) today announced results from a… Read More
KENILWORTH, N.J. — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced new leadership for its Human Health business. Arpa Garay will lead Human Health Global… Read More
Commitment demonstrates support for Indigenous-led solutions that build educational capacity and increase economic prosperity TORONTO – Today, Deloitte Canada announced its first multi-year sponsorship agreement with Indspire, committing $175,000 annually for… Read More
NEW YORK & MIAMI — Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the European Commission has granted marketing authorization for the next-generation long-acting recombinant… Read More
CDN $3-million donation to support diversity in dermatology research, training and care AbbVie, a global research and development-based biopharmaceutical company, has made a CDN $3-million donation to establish a pioneering AbbVie… Read More
